In the present study, we assessed whether human immunodeficiency virus type 1 (HIV-1) genetic compartmentalization was associated with phenotypic CCR5 (R5) or CXCR4 (X4) coreceptor usage differences between the systemic and the genital viral populations. Four clinically asymptomatic and treatment-naïve clade A HIV-1-infected patients were selected from a cohort of 274 African women, because they were free of all the biological cofactors known to modify the kinetics of viral production in the genital tract. HIV RNA envelope sequences (V1 to V3) derived from plasma and cervicovaginal secretions (CVS) were amplified, subcloned, and sequenced. CCR5 or CXCR4 coreceptor usage was determined by production of recombinant viral particles, followed by single-cycle infection assays of indicator cell lines, using the tropism recombinant test. In these four selected patients, CVS-derived sequences appeared to be genetically distinct from blood-derived sequences (P < 0.001). Two patients were found to harbor virus populations with only the R5 phenotype in both compartments, whereas viruses using CXCR4 in addition to CCR5 were detected in two other patients. In particular, one woman harbored genital virus populations with mixed R5 and X4 phenotypes associated with peripheral blood populations with only the R5 phenotype. These results demonstrate genetic compartmentalization of HIV between the plasma and genital secretions of clinically asymptomatic, treatment-naïve, clade A-infected women. Also, for one patient, we report phenotypic coreceptor usage differences between the systemic (R5) and genital (R5/X4) viral populations. These features may be critical for the development of further mucosal vaccines, therapies, or new preventive strategies to block heterosexual transmission.Genital secretions are the source of most human immunodeficiency virus contamination, and more than 90% of new infections are transmitted heterosexually (5). Investigation of the genotypic and phenotypic features of human immunodeficiency virus type 1 (HIV-1) populations from the female genital tract is critical for the development of new therapeutic and preventive strategies to block heterosexual transmission (3, 12). Previous analyses have documented the existence of compartmentalized but phylogenetically related viral sequences between blood and the female genital tract (3, 6). Whether viral genetic compartmentalization is associated with phenotypic CCR5 (R5) or CXCR4 (X4) coreceptor usage differences between the viral populations from the blood and those from the female genital tract has not been directly addressed (3,4,6). Several genetic studies have predicted viral tropism in the female genital tract (4, 6) and have suggested that women infected by subtype B virus may harbor distinct CCR5-tropic or CXCR4-tropic viral populations between blood and the genital tract, whereas those infected with other HIV subtypes do not (4, 6). In a recent report, in which coreceptor usage was determined using a cell-cell fusion assay, R5-tropic variants were found ...